Genetics of gonadotropins and their receptors as markers of ovarian reserve and response in controlled ovarian stimulation

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 44, Issue , 2017, Pages 15-25

  Riccetti, Laura ^a   De Pascali, Francesco ^a   Gilioli, Lisa ^a   Santi, Daniele ^a,b   Brigante, Giulia ^a,b   Simoni, Manuela ^a,b   Casarini, Livio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

ART; FSH; gonadotropins; hCG; LH; ovarian reserve

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; FOLLITROPIN; FOLLITROPIN BETA SUBUNIT; FOLLITROPIN RECEPTOR; GONADOTROPIN; GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE; LUTEINIZING HORMONE BETA SUBUNIT; LUTEINIZING HORMONE RECEPTOR;

FEMALE; FEMALE SUBFERTILITY; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; OOCYTE; OVARIAN RESERVE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY; PRIORITY JOURNAL; RECEPTOR GENE; REPRODUCTIVE SUCCESS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; FEMALE INFERTILITY; GENETIC MARKER; GENETIC POLYMORPHISM; INFERTILITY THERAPY; PROCEDURES;

CHORIONIC GONADOTROPIN; FEMALE; FOLLICLE STIMULATING HORMONE; GENETIC MARKERS; HUMANS; INFERTILITY, FEMALE; LUTEINIZING HORMONE; OVARIAN RESERVE; OVULATION INDUCTION; POLYMORPHISM, GENETIC; RECEPTORS, GONADOTROPIN; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 85019113453     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2017.04.002     Document Type: Review

References (94)

1. Skinner, M.K., Regulation of primordial follicle assembly and development. Hum Reprod Update 11 (2005), 461–471, 10.1093/humupd/dmi020.
2. Jirge, P.R., Poor ovarian reserve. J Hum Reprod Sci 9 (2016), 63–69, 10.4103/0974-1208.183514.
3. Ascoli, M., Fanelli, F., Segaloff, D.L., The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev 23 (2002), 141–174, 10.1210/edrv.23.2.0462.
4. Simoni, M., Gromoll, J., Nieschlag, E., The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18 (1997), 739–773, 10.1210/edrv.18.6.0320.
5. Casarini, L., Moriondo, V., Marino, M., et al. FSHR polymorphism p.N680S mediates different responses to FSH in vitro. Mol Cell Endocrinol 393 (2014), 83–91, 10.1016/j.mce.2014.06.013.
6. Casarini, L., Santi, D., Marino, M., Impact of gene polymorphisms of gonadotropins and their receptors on human reproductive success. Reproduction 150 (2015), R175–R184, 10.1530/REP-15-0251.
7. Creus, M., Peñarrubia, J., Fábregues, F., et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 15 (2000), 2341–2346.
8. La Marca, A., Sighinolfi, G., Argento, C., et al. Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization. Fertil Steril, 99, 2013, 10.1016/j.fertnstert.2013.01.086 970–8.e1.
9. La Marca, A., Sunkara, S.K., Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update 20 (2014), 124–140, 10.1093/humupd/dmt037.
10. Shrestha, D., La, X., Feng, H.L., Comparison of different stimulation protocols used in in vitro fertilization: a review. Ann Transl Med, 3, 2015, 137, 10.3978/j.issn.2305-5839.2015.04.09.
11. Malmusi, S., La Marca, A., Giulini, S., et al. Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation. Fertil Steril 84 (2005), 402–406, 10.1016/j.fertnstert.2005.01.139.
12. Ubaldi, F., Vaiarelli, A., D'Anna, R., et al. Management of poor responders in IVF: is there anything new?. Biomed Res Int, 2014, 2014, 352098, 10.1155/2014/352098.
13. Oehninger, S., Poor responders in in vitro fertilization (IVF) therapy: the challenge continues. Facts Views Vis Obgyn 3 (2011), 101–108.
14. La Marca, A., D'Ippolito, G., Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction. Reprod Biomed Online 28 (2014), 183–190, 10.1016/j.rbmo.2013.10.012.
15. Azziz, R., Introduction: determinants of polycystic ovary syndrome. Fertil Steril 106 (2016), 4–5, 10.1016/j.fertnstert.2016.05.009.
16. Casarini, L., Pignatti, E., Simoni, M., Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function. Rev Endocr Metab Disord 12 (2011), 303–321, 10.1007/s11154-011-9192-2.
17. Greene, A.D., Patounakis, G., Segars, J.H., Genetic associations with diminished ovarian reserve: a systematic review of the literature. J Assist Reprod Genet 31 (2014), 935–946, 10.1007/s10815-014-0257-5.
18. Jameson, J.L., Becker, C.B., Lindell, C.M., et al. Human follicle-stimulating hormone beta-subunit gene encodes multiple messenger ribonucleic acids. Mol Endocrinol 2 (1988), 806–815, 10.1210/mend-2-9-806.
19. Nagirnaja, L., Rull, K., Uusküla, L., et al. Genomics and genetics of gonadotropin beta-subunit genes: unique FSHB and duplicated LHB/CGB loci. Mol Cell Endocrinol 329 (2010), 4–16, 10.1016/j.mce.2010.04.024.
20. Simoni, M., Casarini, L., Mechanisms in endocrinology: genetics of FSH action: a 2014-and-beyond view. Eur J Endocrinol 170 (2014), R91–R107, 10.1530/EJE-13-0624.
21. Grigorova, M., Punab, M., Ausmees, K., et al. FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men. Hum Reprod 23 (2008), 2160–2166, 10.1093/humrep/den216.
22. Grigorova, M., Punab, M., Poolamets, O., et al. Increased prevalance of the −211 T allele of follicle stimulating hormone (FSH) β subunit promoter polymorphism and lower serum FSH in infertile men. J Clin Endocrinol Metab 95 (2010), 100–108, 10.1210/jc.2009-1010.
23. Ferlin, A., Vinanzi, C., Selice, R., et al. Toward a pharmacogenetic approach to male infertility: polymorphism of follicle-stimulating hormone beta-subunit promoter. Fertil Steril, 96, 2011, 10.1016/j.fertnstert.2011.09.034 1344–1349.e2.
24. Grigorova, M., Punab, M., Zilaitienė, B., et al. Genetically determined dosage of follicle-stimulating hormone (FSH) affects male reproductive parameters. J Clin Endocrinol Metab 96 (2011), E1534–E1541, 10.1210/jc.2011-0632.
25. Schüring, A.N., Busch, A.S., Bogdanova, N., et al. Effects of the FSH-β-subunit promoter polymorphism -211G->T on the hypothalamic-pituitary-ovarian axis in normally cycling women indicate a gender-specific regulation of gonadotropin secretion. J Clin Endocrinol Metab 98 (2013), E82–E86, 10.1210/jc.2012-2780.
26. Ruth, K.S., Beaumont, R.N., Tyrrell, J., et al. Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health. Hum Reprod 31 (2016), 473–481, 10.1093/humrep/dev318.
27. La Marca, A., Papaleo, E., Alviggi, C., et al. The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age. Hum Reprod 28 (2013), 1369–1374, 10.1093/humrep/det061.
28. Desai, S.S., Roy, B.S., Mahale, S.D., Mutations and polymorphisms in FSH receptor: functional implications in human reproduction. Reproduction 146 (2013), R235–R248, 10.1530/REP-13-0351.
29. Vaskivuo, T.E., Aittomäki, K., Anttonen, M., et al. Effects of follicle-stimulating hormone (FSH) and human chorionic gonadotropin in individuals with an inactivating mutation of the FSH receptor. Fertil Steril 78 (2002), 108–113, 10.1016/S0015-0282(02)03148-5.
30. Ilgaz, N.S., Aydos, O.S.E., Karadag, A., et al. Impact of follicle-stimulating hormone receptor variants in female infertility. J Assist Reprod Genet 32 (2015), 1659–1668, 10.1007/s10815-015-0572-5.
31. Ulloa-Aguirre, A., Reiter, E., Bousfield, G., et al. Constitutive activity in gonadotropin receptors. Adv Pharmacol 70 (2014), 37–80, 10.1016/B978-0-12-417197-8.00002-X.
32. Gromoll, J., Simoni, M., Nordhoff, V., et al. Functional and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol 125 (1996), 177–182.
33. Gromoll, J., Simoni, M., Nieschlag, E., An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab 81 (1996), 1367–1370.
34. Perez Mayorga, M., Gromoll, J., Behre, H.M., et al. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 85 (2000), 3365–3369, 10.1210/jcem.85.9.6789.
35. Achrekar, S., Modi, D., Desai, S., et al. Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism. Reprod Biomed Online 18 (2009), 509–515, 10.1016/S1472-6483(10)60127-7.
36. Mohiyiddeen, L., Newman, W.G., McBurney, H., et al. Follicle-stimulating hormone receptor gene polymorphisms are not associated with ovarian reserve markers. Fertil Steril 97 (2012), 677–681, 10.1016/j.fertnstert.2011.12.040.
37. Behre, H.M., Greb, R.R., Mempel, A., et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 15 (2005), 451–456.
38. Huang, X., Li, L., Hong, L., et al. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation. Clin Endocrinol (Oxf) 82 (2015), 577–583, 10.1111/cen.12573.
39. Zerbetto, I., Gromoll, J., Luisi, S., et al. Follicle-stimulating hormone receptor and DAZL gene polymorphisms do not affect the age of menopause. Fertil Steril 90 (2008), 2264–2268, 10.1016/j.fertnstert.2007.10.036.
40. Mukherjee, T., Copperman, A.B., Lapinski, R., et al. An elevated day three follicle-stimulating hormone: luteinizing hormone ratio (FSH: LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril 65 (1996), 588–593.
41. Daelemans, C., Smits, G., de Maertelaer, V., et al. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab 89 (2004), 6310–6315, 10.1210/jc.2004-1044.
42. Boudjenah, R., Molina-Gomes, D., Torre, A., et al. Genetic polymorphisms influence the ovarian response to rFSH stimulation in patients undergoing in vitro fertilization programs with ICSI. PLoS One, 7, 2012, e38700, 10.1371/journal.pone.0038700.
43. Valkenburg, O., van Santbrink, E.J.P., König, T.E., et al. Follicle-stimulating hormone receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (World Health Organization class 2) anovulatory subfertility. Fertil Steril, 103, 2015, 10.1016/j.fertnstert.2015.01.002 1081–1088.e3.
44. Wunsch, A., Ahda, Y., Banaz-Yaşar, F., et al. Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle-stimulating hormone receptor. Fertil Steril 84 (2005), 446–453, 10.1016/j.fertnstert.2005.02.031.
45. Desai, S.S., Achrekar, S.K., Pathak, B.R., et al. Follicle-stimulating hormone receptor polymorphism (G-29A) is associated with altered level of receptor expression in Granulosa cells. J Clin Endocrinol Metab 96 (2011), 2805–2812, 10.1210/jc.2011-1064.
46. Busch, A.S., Hagen, C.P., Almstrup, K., et al. Genetic variations altering FSH action affect circulating hormone levels as well as follicle growth in healthy peripubertal girls. Hum Reprod 31 (2016), 897–904.
47. Shi, Y., Zhao, H., Shi, Y., et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet 44 (2012), 1020–1025, 10.1038/ng.2384.
48. Overbeek, A., Kuijper, E.A.M., Hendriks, M.L., et al. Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome. Hum Reprod 24 (2009), 2007–2013, 10.1093/humrep/dep114.
49. Casarini, L., Lispi, M., Longobardi, S., et al. LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling. PLoS One, 7, 2012, e46682, 10.1371/journal.pone.0046682.
50. Casarini, L., Riccetti, L., De Pascali, F., et al. Follicle-stimulating hormone potentiates the steroidogenic activity of chorionic gonadotropin and the anti-apoptotic activity of luteinizing hormone in human granulosa-lutein cells in vitro. Mol Cell Endocrinol 422 (2016), 103–114, 10.1016/j.mce.2015.12.008.
51. Lofrano-Porto, A., Barra, G.B., Giacomini, L.A., et al. Luteinizing hormone beta mutation and hypogonadism in men and women. N Engl J Med 357 (2007), 897–904, 10.1056/NEJMoa071999.
52. Achard, C., Courtillot, C., Lahuna, O., et al. Normal spermatogenesis in a man with mutant luteinizing hormone. N Engl J Med 361 (2009), 1856–1863, 10.1056/NEJMoa0805792.
53. Basciani, S., Watanabe, M., Mariani, S., et al. Hypogonadism in a patient with two novel mutations of the luteinizing hormone β-subunit gene expressed in a compound heterozygous form. J Clin Endocrinol Metab 97 (2012), 3031–3038, 10.1210/jc.2012-1986.
54. Furui, K., Suganuma, N., Tsukahara, S., et al. Identification of two point mutations in the gene coding luteinizing hormone (LH) beta-subunit, associated with immunologically anomalous LH variants. J Clin Endocrinol Metab 78 (1994), 107–113, 10.1210/jcem.78.1.7904610.
55. Takahashi, K., Ozaki, T., Okada, M., et al. Increased prevalence of luteinizing hormone beta-subunit variant in patients with premature ovarian failure. Fertil Steril 71 (1999), 96–101.
56. Ramanujam, L.N., Liao, W.X., Roy, A.C., et al. Association of molecular variants of luteinizing hormone with menstrual disorders. Clin Endocrinol (Oxf) 51 (1999), 243–246.
57. Alviggi, C., Clarizia, R., Pettersson, K., et al. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod Biomed Online 22 (2011), S67–S72, 10.1016/S1472-6483(11)60011-4.
58. Alviggi, C., Pettersson, K., Longobardi, S., et al. A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology. Reprod Biol Endocrinol, 11, 2013, 51, 10.1186/1477-7827-11-51.
59. Julier, C., Weil, D., Couillin, P., et al. The beta chorionic gonadotropin-beta luteinizing gene cluster maps to human chromosome 19. Hum Genet 67 (1984), 174–177.
60. Birken, S., Canfield, R.E., Isolation and amino acid sequence of COOH-terminal fragments from the beta subunit of human choriogonadotropin. J Biol Chem 252 (1977), 5386–5392.
61. Casarini, L., Brigante, G., Simoni, M., et al. Clinical applications of gonadotropins in the female: assisted reproduction and beyond. Prog Mol Biol Transl Sci 143 (2016), 85–119, 10.1016/bs.pmbts.2016.08.002.
62. Rai, R., Regan, L., Recurrent miscarriage. Lancet 368 (2006), 601–611, 10.1016/S0140-6736(06)69204-0.
63. Rull, K., Nagirnaja, L., Ulander, V.-M., et al. Chorionic gonadotropin β-gene variants are associated with recurrent miscarriage in two European populations. J Clin Endocrinol Metab 93 (2008), 4697–4706, 10.1210/jc.2008-1101.
64. Gromoll, J., Lahrmann, L., Godmann, M., et al. Genomic checkpoints for exon 10 usage in the luteinizing hormone receptor type 1 and type 2. Mol Endocrinol 21 (2007), 1984–1996, 10.1210/me.2006-0506.
65. Gromoll, J., Eiholzer, U., Nieschlag, E., et al. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab 85 (2000), 2281–2286, 10.1210/jcem.85.6.6636.
66. Grzesik, P., Kreuchwig, A., Rutz, C., et al. Differences in signal activation by LH and hCG are mediated by the LH/CG receptor's extracellular hinge region. Front Endocrinol (Lausanne), 2015, 6, 10.3389/fendo.2015.00140.
67. Gromoll, J., Wistuba, J., Terwort, N., et al. A new subclass of the luteinizing hormone/chorionic gonadotropin receptor lacking exon 10 messenger RNA in the New World monkey (Platyrrhini) lineage. Biol Reprod 69 (2003), 75–80, 10.1095/biolreprod.102.014902.
68. Kossack, N., Simoni, M., Richter-Unruh, A., et al. Mutations in a novel, cryptic exon of the luteinizing hormone/chorionic gonadotropin receptor gene cause male pseudohermaphroditism. PLoS Med, 5, 2008, e88, 10.1371/journal.pmed.0050088.
69. Kossack, N., Troppmann, B., Richter-Unruh, A., et al. Aberrant transcription of the LHCGR gene caused by a mutation in exon 6A leads to Leydig cell hypoplasia type II. Mol Cell Endocrinol 366 (2013), 59–67, 10.1016/j.mce.2012.11.018.
70. Troppmann, B., Kleinau, G., Krause, G., et al. Structural and functional plasticity of the luteinizing hormone/choriogonadotrophin receptor. Hum Reprod Update 19 (2013), 583–602, 10.1093/humupd/dmt023.
71. Latronico, A.C., Anasti, J., Arnhold, I.J., et al. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 334 (1996), 507–512, 10.1056/NEJM199602223340805.
72. Toledo, S.P., Brunner, H.G., Kraaij, R., et al. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J Clin Endocrinol Metab 81 (1996), 3850–3854, 10.1210/jcem.81.11.8923827.
73. Latronico, A.C., Chai, Y., Arnhold, I.J.P., et al. A homozygous microdeletion in Helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol Endocrinol 12 (1998), 442–450, 10.1210/mend.12.3.0077.
74. Stavrou, S.S., Zhu, Y.S., Cai, L.Q., et al. A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters. J Clin Endocrinol Metab 83 (1998), 2091–2098, 10.1210/jcem.83.6.4855.
75. Bruysters, M., Christin-Maitre, S., Verhoef-Post, M., et al. A new LH receptor splice mutation responsible for male hypogonadism with subnormal sperm production in the propositus, and infertility with regular cycles in an affected sister. Hum Reprod 23 (2008), 1917–1923, 10.1093/humrep/den180.
76. Arnhold, I.J., Lofrano-Porto, A., Latronico, A.C., Inactivating mutations of luteinizing hormone β-subunit or luteinizing hormone receptor cause oligo-amenorrhea and infertility in women. Horm Res Paediatr 71 (2009), 75–82, 10.1159/000183895.
77. Onalan, G., Pabuçcu, R., Onalan, R., et al. Empty follicle syndrome in two sisters with three cycles: case report. Hum Reprod 18 (2003), 1864–1867.
78. Yariz, K.O., Walsh, T., Uzak, A., et al. Inherited mutation of the luteinizing hormone/choriogonadotropin receptor (LHCGR) in empty follicle syndrome. Fertil Steril 96 (2011), e125–e130, 10.1016/j.fertnstert.2011.05.057.
79. Bentov, Y., Kenigsberg, S., Casper, R.F., A novel luteinizing hormone/chorionic gonadotropin receptor mutation associated with amenorrhea, low oocyte yield, and recurrent pregnancy loss. Fertil Steril 97 (2012), 1165–1168, 10.1016/j.fertnstert.2012.02.002.
80. Rosenthal, I.M., Refetoff, S., Rich, B., et al. Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor–a clinical research center study. J Clin Endocrinol Metab 81 (1996), 3802–3806, 10.1210/jcem.81.10.8855841.
81. Shenker, A., Laue, L., Kosugi, S., et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365 (1993), 652–654, 10.1038/365652a0.
82. Latronico, A.C., Lins, T.S., Brito, V.N., et al. The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary-gonadal axis in both sexes. Clin Endocrinol (Oxf) 53 (2000), 609–613.
83. El-Shal, A.S., Zidan, H.E., Rashad, N.M., et al. Association between genes encoding components of the leutinizing hormone/luteinizing hormone-choriogonadotrophin receptor pathway and polycystic ovary syndrome in Egyptian women. IUBMB Life 68 (2016), 23–36.
84. Capalbo, A., Sagnella, F., Apa, R., et al. The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population. Clin Endocrinol (Oxf) 77 (2012), 113–119.
85. Simoni, M., Tüttelmann, F., Michel, C., et al. Polymorphisms of the luteinizing hormone/chorionic gonadotropin receptor gene: association with maldescended testes and male infertility. Pharmacogenet Genomics 18 (2008), 193–200, 10.1097/FPC.0b013e3282f4e98c.
86. Thathapudi, S., Kodati, V., Erukkambattu, J., et al. Association of luteinizing hormone chorionic gonadotropin receptor gene polymorphism (rs2293275) with polycystic ovarian syndrome. Genet Test Mol Biomark 19 (2015), 128–132, 10.1089/gtmb.2014.0249.
87. Papamentzelopoulou, M., Mavrogianni, D., Partsinevelos, G.A., et al. LH receptor gene expression in cumulus cells in women entering an ART program. J Assist Reprod Genet 29 (2012), 409–416, 10.1007/s10815-012-9729-7.
88. Younis, J.S., Haddad, S., Matilsky, M., et al. Premature luteinization: could it be an early manifestation of low ovarian reserve?. Fertil Steril 69 (1998), 461–465.
89. Tüttelmann, F., Laan, M., Grigorova, M., et al. Combined effects of the variants FSHB −211G>T and FSHR 2039A>G on male reproductive parameters. J Clin Endocrinol Metab 97 (2012), 3639–3647, 10.1210/jc.2012-1761.
90. Lindgren, I., Bååth, M., Uvebrant, K., et al. Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization. Hum Reprod 31 (2016), 672–683, 10.1093/humrep/dev342.
91. Allegra, A., Marino, A., Raimondo, S., et al. The carriers of the A/G-G/G allelic combination of the c.2039 A>G and c.-29 G>A FSH receptor polymorphisms retrieve the highest number of oocytes in IVF/ICSI cycles. J Assist Reprod Genet, 2016.
92. Pennell, T.M., Morrow, E.H., Two sexes, one genome: the evolutionary dynamics of intralocus sexual conflict. Ecol Evol 3 (2013), 1819–1834.
93. Casarini, L., Simoni, M., Brigante, G., Is polycystic ovary syndrome a sexual conflict? A review. Reprod Biomed Online 32 (2016), 350–361, 10.1016/j.rbmo.2016.01.011.
94. Casarini, L., Brigante, G., The polycystic ovary syndrome evolutionary paradox: a genome-wide association studies-based, in silico, evolutionary explanation. J Clin Endocrinol Metab 99 (2014), E2412–E2420.